Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | (FY)Sep 30, 2019 | (FY)Sep 30, 2018 | (FY)Sep 30, 2017 | (FY)Sep 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 8.83%120.87B | -1.88%111.06B | -14.76%113.19B | 14.08%132.79B | 57.90%116.4B | 14.95%73.71B | 19.19%64.13B | -40.37%53.8B | -15.79%90.23B | 53.78%107.14B |
| Cash income from bank and customer deposits | 49.77%51.85B | 230.04%34.62B | -86.11%10.49B | 35.01%75.53B | 116.08%55.94B | 59.08%25.89B | --16.28B | ---- | 13.24%43.71B | 2,054.07%38.6B |
| Cash income from loans | -2.46%57.27B | 24.03%58.72B | 77.70%47.34B | -32.08%26.64B | 5.34%39.22B | 26.34%37.23B | 3.16%29.47B | 5.12%28.57B | -11.93%27.18B | 0.51%30.86B |
| Cash income from securities-related activities | -58.51%5.27B | -74.83%12.69B | 311.02%50.42B | -17.67%12.27B | 127.47%14.9B | -43.09%6.55B | -29.53%11.51B | 94.39%16.33B | -21.70%8.4B | 3.55%10.73B |
| Other cash income from operating activities | 28.68%6.48B | 1.76%5.03B | -73.05%4.95B | 189.83%18.35B | 56.69%6.33B | -41.20%4.04B | -22.80%6.87B | -18.64%8.9B | -59.40%10.94B | 0.71%26.95B |
| Cash paid | 23.49%-112.35B | -4.97%-146.84B | -33.78%-139.89B | 9.57%-104.57B | -190.38%-115.64B | 25.87%-39.82B | 14.73%-53.72B | 18.20%-63B | 16.91%-77.01B | -11.99%-92.68B |
| Cash paid for bank and customer deposits | ---- | ---- | 53.52%-9.16B | 68.44%-19.7B | -527.88%-62.43B | -1,656.71%-9.94B | 73.21%-566M | ---2.11B | ---- | ---- |
| Cash paid for loan | 11.24%-49.43B | -111.58%-55.69B | 50.69%-26.32B | -55.32%-53.38B | ---34.37B | ---- | 27.35%-20.15B | 19.13%-27.74B | 25.24%-34.3B | -16.18%-45.88B |
| Cash paid for interest and commission | 0.45%-40.39B | -42.13%-40.58B | -336.25%-28.55B | -42.60%-6.54B | 54.79%-4.59B | 36.52%-10.15B | -8.21%-15.99B | -3.23%-14.78B | 8.19%-14.32B | 8.33%-15.59B |
| All taxes paid | -11.40%-3.16B | 4.68%-2.83B | -81.17%-2.97B | 10.47%-1.64B | 28.95%-1.83B | -14.62%-2.58B | 14.54%-2.25B | -3.54%-2.63B | 19.19%-2.54B | -29.65%-3.15B |
| Other cash payments from operating activities | 59.43%-19.37B | 34.51%-47.74B | -212.91%-72.89B | -87.64%-23.3B | 27.60%-12.42B | -16.23%-17.15B | 6.21%-14.75B | 39.15%-15.73B | 7.88%-25.85B | -48.01%-28.06B |
| Operating cash flow | 123.79%8.51B | -34.02%-35.78B | -194.61%-26.7B | 3,618.18%28.22B | -97.76%759M | 225.57%33.89B | 213.20%10.41B | -169.58%-9.2B | -8.60%13.22B | 210.47%14.46B |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 2.15%-1.41B | -20.72%-1.44B | -10.68%-1.19B | -25.67%-1.08B | 4.67%-857M | 19.30%-899M | -7.95%-1.11B | -1.78%-1.03B | -23.21%-1.01B | -9.44%-823M |
| Net business purchase and sale | -101.00%-1M | 21.95%100M | 102.72%82M | -830.83%-3.01B | 398.55%412M | -250.00%-138M | 127.46%92M | -114.62%-335M | 119.45%2.29B | -7,604.46%-11.78B |
| Net investment property transactions | -171.29%-4.3B | 294.52%6.03B | 32.83%-3.1B | -42.04%-4.62B | -1,069.85%-3.25B | -90.78%335M | 780.15%3.64B | 125.96%413M | -160.38%-1.59B | 313.36%2.64B |
| Investing cash flow | -221.68%-5.71B | 211.43%4.69B | 51.63%-4.21B | -135.60%-8.7B | -426.21%-3.69B | -126.87%-702M | 373.90%2.61B | -204.79%-954M | 96.86%-313M | -444.81%-9.97B |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | -44.67%9.49B | 32.62%17.14B | -12.48%12.93B | 190.45%14.77B | 14.41%-16.33B | -585.56%-19.08B | -130.43%-2.78B | 89.81%9.15B | -65.80%4.82B | 1,251.06%14.09B |
| Net common stock issuance | 61.55%-1B | -61.17%-2.61B | 63.32%-1.62B | -579.54%-4.42B | -113.25%-650M | 390.40%4.9B | --1B | ---- | ---- | ---- |
| Net preferred stock issuance | -248.51%-600M | 20.24%404M | --336M | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Increase or decrease of lease financing | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash dividends paid | -2.72%-4.83B | -8.32%-4.7B | -8.31%-4.34B | -49.37%-4.01B | -15.45%-2.68B | 28.87%-2.32B | 22.62%-3.27B | 11.14%-4.22B | -3.42%-4.75B | -26.74%-4.59B |
| Net other fund-raising expenses | -4.67%-336M | 2.13%-321M | 3.24%-328M | 85.77%-339M | -640.06%-2.38B | 55.40%-322M | ---722M | ---- | ---400M | ---- |
| Financing cash flow | -72.59%2.72B | 42.14%9.92B | 16.09%6.98B | 127.26%6.01B | -31.06%-22.05B | -191.46%-16.82B | -217.15%-5.77B | 1,588.22%4.93B | -103.49%-331M | 616.14%9.5B |
| Net cash flow | ||||||||||
| Beginning cash position | -53.59%18.84B | -34.72%40.59B | 64.14%62.18B | -38.94%37.88B | 31.93%62.04B | 23.93%47.03B | -4.66%37.95B | 42.35%39.8B | 36.20%27.96B | -22.59%20.53B |
| Current changes in cash | 126.07%5.52B | 11.53%-21.17B | -193.76%-23.93B | 202.19%25.53B | -252.60%-24.98B | 125.73%16.37B | 238.82%7.25B | -141.55%-5.22B | -10.10%12.57B | 202.88%13.99B |
| Effect of exchange rate changes | 179.62%461M | -124.71%-579M | 290.64%2.34B | -249.88%-1.23B | 160.52%820M | -174.12%-1.36B | -45.76%1.83B | 559.75%3.37B | 88.82%-733M | -186.18%-6.55B |
| End cash Position | 31.76%24.82B | -53.59%18.84B | -34.72%40.59B | 64.14%62.18B | -38.94%37.88B | 31.93%62.04B | 23.93%47.03B | -4.66%37.95B | 42.35%39.8B | 36.20%27.96B |
| Free cash flow | 119.08%7.1B | -33.45%-37.22B | -202.75%-27.89B | 27,518.18%27.14B | -100.30%-99M | 254.93%32.92B | 190.51%9.28B | -184.07%-10.25B | -10.28%12.19B | 196.58%13.59B |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |